Joselin Leyva, APRN

Joselin Leyva practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Joselin Leyva's NPI, 1770052797, was assigned on November 20, 2018. Joselin Leyva holds Florida license APRN11000412.

Joselin Leyva's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Joselin Leyva's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Joselin Leyva to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Joselin Leyva practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Joselin Leyva's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Joselin Leyva is licensed in Florida.

Dmand AI lists tobacco use among the conditions Joselin Leyva treats.

CMS data shows 15 Medicare services from Joselin Leyva across 1 procedure code in 2024, all of them office visits, for 21 Medicare patients. Medicare paid $707 for them. Every service was in an office.

CMS counts 21 Medicare patients who saw Joselin Leyva in 2024. 71% of them have high blood pressure, and 71% have high cholesterol. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Joselin Leyva's median patient age at 75, with 57% women.

In 2024, Joselin Leyva wrote 158 Medicare Part D claims for 78 patients. 89% of them were for generic drugs. CMS names the drug for 68 of them, across 3 drugs with 11 or more claims each, at $1,101 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Joselin Leyva for performance year 2024, reported as part of a group. Joselin Leyva accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Joselin Leyva as offering telehealth.

CMS Open Payments shows 22 general payments to Joselin Leyva from 10 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 88% of the total. Janssen Pharmaceuticals, Inc paid the most, $265.